Jeffrey Murray Burns

The paper benchmarks proteomic biomarkers and drug targets in patient-derived cerebral organoids against clinical cohorts, finding they detect most candidates and replicate disease changes in a quarter of reproducible markers.

The paper presents a harmonized framework for analyzing large-scale plasma proteomics data across neurodegenerative diseases, identifying disease-specific circulating signatures and biomarkers.

The paper develops a functional MRI atlas for hypertensive older adults, addressing age-related changes not captured by standard atlases.

This study identifies novel Alzheimer's disease risk loci by analyzing multi-ancestry GWAS data from diverse populations, highlighting the importance of including underrepresented groups in genetic research.

This study identifies blood-based biomarkers associated with Alzheimer's disease genetic risk variants in a large cohort of healthy adults, showing effects from early adulthood and sex-specific patterns.